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ABSTRACT
The X-linked Plac1 gene is maternally expressed in tropho-
blast cells during placentation, and its disruption causes
placental hyperplasia and intrauterine growth restriction. In
contrast, Plac1 is also reported to be one of the upregulated
genes in the hyperplastic placenta generated by nuclear transfer.
However, the effect of overexpressed Plac1 on placental
formation and function remained unaddressed. We comple-
mented the Plac1 knockout placental dysfunction by lentiviral
vector-mediated, placenta-specific Plac1 transgene expression.
Whereas fetal development and the morphology of maternal
blood sinuses in the labyrinth zone improved, placental
hyperplasia remained, with an expanded the junctional zone
that migrated and encroached into the labyrinth zone. Further
experiments revealed that wild-type placenta with transgenically
expressed Plac1 resulted in placental hyperplasia without the
encroaching of the junctional zone. Our findings suggest that
Plac1 is involved in trophoblast cell proliferation, differentia-
tion, and migration. Its proper expression is required for normal
placentation and fetal development.
imprinting, intrauterine growth restriction, knockout, lentiviral
vector, nuclear transfer
INTRODUCTION
The placenta is a fetomaternal interface that is required for
nutrient supply and gas exchange during gestation. The
investigation of the function of trophoblast-related genes is
important to understand not only placental development but
also pregnancy-related diseases. Plac1 is an X-linked gene that
is mainly expressed in the trophoblast lineage, such as
trophoblast giant cells and labyrinth trophoblast cells in mice
[1]. In humans, PLAC1 expression is also restricted to
trophoblast cell lineage and enriched specifically in the
microvillous membrane surface of the syncytiotrophoblast
cells [2, 3].
Research literature has implicated the importance of
PLAC1 in normal placentation. The Xq26 region of the X-
chromosome, including CR59647, GPC-3, HPRT,
MGC16121, PHF6, and PLAC1, has been implicated in
human placental dysplasia, and PLAC1 is the only gene that
proved to be specifically expressed in placenta [1]. Down-
regulation of Plac1 was also reported in hyperplastic placenta
associated with interspecific hybrid placental dysplasia (Ihpd)
between Mus musculus and Mus spretus [4–6]. To directly
address Plac1 function in vivo, Jackman et al. [7] generated
Plac1 disrupted mice and found placental hyperplasia, with
the junctional zone encroaching into the labyrinth zone in the
conspectuses carrying maternally transmitted mutant X-
chromosome. Intrauterine growth restriction and semilethality
were observed in these embryos.
By contrast, microarray studies reveal that the Plac1 gene
was consistently upregulated in the hyperplastic placenta of a
mouse cloned by nuclear transfer (NT) [8]. It is noteworthy that
NT-cloned placenta also had an enlarged junctional zone that
encroached into labyrinth zone [9]. One possible interpretation
is that Plac1 upregulation is caused by placental hyperplasia.
Another possibility is that placental hyperplasia might be
caused by an overexpression of Plac1.
In the present study, we first analyzed Plac1 expression in
preimplantation and postimplantation embryos, then generat-
ed Plac1 knockout (KO) mice to examine the gene’s
importance for embryonic development. Second, we applied
the lentiviral (LV) vector-mediated, placenta-specific trans-
gene expression system to complement Plac1 deficiency in
KO mice. Finally, to answer the questions mentioned above,
we transgenically expressed Plac1 in wild-type (WT) placenta
and compared the phenotypes with KO and LV-complement-
ed KO placentas. Our results suggest that the proper




All animal experiments were approved by the Institutional Animal Care and
Use Committee of the Research Institute for Microbial Diseases, Osaka
University. The Plac1-deficient mouse line (B6D2F1-Plac1Tm1[KOMP]7Osb) and
X-linked EGFP mouse line (B6;B6C3-Tg[CAG/Acr-EGFP]CX-FM139Osb)
were available to the scientific community through RIKEN BRC (http://www.
brc.riken.jp/inf/en/index.shtml).
Reverse Transcription-Polymerase Chain Reaction
Mouse cDNA was prepared from blastocyst (Embryonic Day 3.5 [E3.5])
and early gestational- to midgestational-stage embryos (E6.5;E7.5). The RT-
PCR was performed using 10 ng of cDNA and the following primers: 50-
ATGAACCTTCGCAAGTTCCTGGG-3 0 and 5 0-TTACATGCTCTTTT
GATTGTAGACATAAGGTGG-3 0 for Plac1, 5 0-AAGTGTGACGTTGA
CATCCG-30 and 50-GATCCACATCTGCTGGAAGG-30 for beta actin (b-
actin), and 50-ATCCTCTGCATGGTCAGGTC-30 and 50-CGTGGCCTGATT
CATTCC-30 for lacZ. [10]. The amplification cycles were 948C for 30 sec,
658C for 30 sec, and 728C for 30 sec, with a final 2 min of extension at 728C.
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Quantitative RT-PCR
Mouse cDNA was prepared from blastocyst (E3.5) and placenta (E16.5).
Each cDNA was subjected to quantitative RT-PCR analysis with a Thermal
Cycler Dice TP800 (Takara-Bio) using SYBR Premix Ex Taq II RR820S
(Takara-Bio). The relative expression level of each target gene mRNA was
normalized to the amount of b-actin control. Each reaction was performed in
duplicate, and data are presented as the mean plus SD. Primer sets were as
follows: 5 0-GCGTTACCGAATGTGGCATC-3 0 and 5 0-CAGCTG
CAGTTGGGTTGTTC-3 0 for Plac1, and 5 0-AAGTGTGACGTTGA
CATCCG-30 and 50-GATCCACATCTGCTGGAAGG-30 for b-actin.
Generation of Plac1 Gene-Deficient Mice
Plac1 gene-targeting vector (DPGS00170_A_E06) was purchased from the
International Knockout Mouse Consortium (IKMC). After linearization with
AsiSI digestion, the targeting vector was electroporated into EGR-G101
embryonic stem (ES) cells [11]. After positive (G418) and negative (DT)
selection, among the 48 drug-resistant clones 14 clones were identified as
homologous recombinant clones by PCR screening with primers 5 0-
C A C A A C G G G T T C T T C T G T T A G T C C- 3 0 a n d 5 0- G T C T G G C C
TGCTGTGGAGTTGAGAGTCTTG-30 for the 50 end, and 50-ATCCGGGGG
TACCGCGTCGAG-3 0 and 5 0-CAGACAGGACAGAAGCGGTTCTGCA
GAG-30 for the 30 end. The gene-targeted ES cells were injected into eight-
cell-stage ICR mouse embryos to generate chimeric mice. Germ line
transmission of mutant Plac1 allele (X–) was confirmed by PCR with primers
Pr1, 50-GTTCACTCAGATGATCTGAGGAAACCC-30; Pr2, 50-ACCCAGG
CACCAATGCTAGC-30; and Pr3, 50-ATCCGGGGGTACCGCGTCGAG-30.
These mice were mated with B6D2F1 mice and used for further experiments.
Maternally and paternally transmitted mutant alleles are referred to as Xm– and
Xp–, respectively.
Blastocyst Collection and Sex Determination
Female mice were superovulated by i.p. injection of a pregnant mare’s
serum gonadotropin (5 units) followed by human chorionic gonadotropin (5
units) 48 h later, and then they were mated with male mice. Two-cell-stage
embryos were collected from the females at 1.5 days after copulation and then
incubated in KSOM medium for 2 days to obtain blastocysts. For gender
selection, the blastocysts collected from WT female mice mated with XegfpY
(B6;B6C3-Tg[CAG/Acr-EGFP]CX-FM139Osb) male mice were separated into
male (EGFP-negative) and female (EGFP-positive) blastocysts under a
fluorescence stereomicroscope [12]. The RNA collected from these gender-
specific blastocysts was pooled and subjected to RT-PCR for Plac1 expression
analysis. For genotyping experiments, each blastocyst was placed in 20 ll of
lysis buffer (20 mM Tris-HCl [pH 8.0], 5 mM ethylene diamine tetraacetic acid,
400 mM NaCl, SDS 0.3%, and 200 lg/ml Proteinase K), and 0.5 ll was
subjected to PCR analysis. Plac1 genotype was performed with the above-
ment ioned pr imers , and Ube1X primers 5 0-TGGTCTGGACC
CAAACGCTGTCCACA-30 and 5 0-GGCAGCAGCCATCACATAATCCA
GATG-30 were used for sexing [13].
Tissue Preparation and Histological Analysis
At E3.5 through E16.5, the pregnant mice were killed, and their uteri were
dissected to collect embryonic or extraembryonic tissues. For embryos at E6.5
through E9.5, the uteri were removed and conceptuses were used for RT-PCR.
For embryos at E12.5 through E16.5, the uteri were removed and individual
fetuses were dissected from the uterus with embryonic membranes intact.
Placentas were fixed in 4% paraformaldehyde in PBS and were processed for
paraffin embedding or frozen section. The 5-lm paraffin sections were stained
with periodic acid-Schiff (PAS) and then counterstained with Mayer
hematoxylin solution (Wako). The 10-lm frozen sections were stained with
X-Gal to detect b-galactosidase (b-gal) activity (LacZ Tissue Staining Kit;
InvivoGen), then counterstained with 0.3% eosin for 2 min, rinsed in 70%
ethanol, dehydrated in increasing ethanol concentrations, and finally mounted
in Entellan new (Merck).
Immunohistochemical Analysis
The sliced sections were incubated with 1% bovine serum albumin in PBS
for 1 h to block nonspecific reactions. These were then incubated overnight
with the following primary antibodies: anti-Laminin antibody (no. L9393;
Sigma-Aldrich) to stain the endothelial basement membrane of fetal capillaries
[14], and anti-Ki67 antibody (no. 12202; Cell Signaling Technology) to stain
the proliferating cells. After incubation with secondary antibodies conjugated
with horseradish peroxidase, we used diaminobenzidine tetrahydrochloride
(DAB; Nacalai Tesque) to stain the sliced sections with a hematoxylin
counterstain.
Morphometric Quantification of Placenta
The centerlines of each of the maternal blood sinuses in the labyrinth zone
of the placenta were manually selected, and the widths were measured. We
analyzed 20 sinuses in 3 areas for 3 placentas per group. Each placental layer
was manually selected, and the areas were measured. We analyzed three
placentas per group. The images were analyzed with ImageJ software (National
Institutes of Health).
Preparation of Lentiviral Vectors
The HIV-1-based, self-inactivating lentiviral vector plasmid pLV-EGFP
was described previously [15]. Mouse Plac1 cDNA was amplified by RT-PCR
using placental tissue with primers 5 0-ATCTAGAGCCGCCAT
G A A C C T T C G C A A G T T C C T G G G - 3 0 a n d 5 0- A G A A T T C T T A
CATGCTCTTTTGATTGTAGACATAAGGTGG-30. A 0.5-kb XbaI-EcoRI
Plac1 fragment was inserted into lentiviral vector plasmid under the CAG
promoter (pLV-Plac1). The pLV-Plac1 plasmid was transfected to 293T cells
by the calcium phosphate method. Lentiviral vectors were harvested 2 days
after transfection, and then they were concentrated 1000 times by ultracentri-
fugation (19 400 rpm, 2 h; 21 000 rpm, 2 h). After resuspension with Hanks
Balanced Salt Solution buffer, the lentiviral vector concentration was
determined by measuring p24 gag antigens by ELISA [15].
Lentiviral Transduction for Mouse Blastocysts
Blastocysts were collected as described above. To remove the zona
pellucida, the blastocysts were incubated in acidic Tyrode solution (Sigma-
Aldrich) for 30–60 sec and washed three times in KSOM. Prepared zona
pellucida-free blastocysts were incubated individually for 4 h in medium
containing lentiviral vectors. LV-EGFP and LV-Plac1 were used at 1000 ng of
p24 per milliliter. The transduced blastocysts were implanted into the uteri of
pseudopregnant E2.5 ICR female mice. We transplanted 10 blastocysts into
each horn of the uterus.
Statistical Analysis
All values are shown as the mean 6 SD of at least three independent
experiments. Statistical analyses were performed using Student t-test inserted in
Excel after the data were tested for normality of distribution.
RESULTS
Allele-Specific Expression of Plac1 Gene
Whereas maternally imprinted Plac1 expresses after
implantation and Plac1 KO mice tend to succumb some-
where between late gestation and weaning [7], Plac1
expression and its physiological role have not been
examined in preimplantation embryos. Thus, we examined
Plac1 expression in blastocyst-stage embryos. When we
mated WT female mice with transgenic male mice carrying
the EGFP-expressing transgene on the X chromosome
(Xegfp) [12], blastocysts could be separated into fluorescent
female blastocysts (XXegfp) and nonfluorescent male blas-
tocysts (XY) under a fluorescent stereomicroscope. By RT-
PCR, we found that Plac1 expression in female blastocysts
was higher than in the male blastocysts, indicating paternally
imprinted gene expression (Fig. 1, A and B). Soon after
implantation, maternal Plac1 started expression, and both
sexes of embryos expressed equivalent amounts of Plac1,
implicating silencing of paternal Plac1 expression (Fig. 1, A
and B).
Generation of Plac1 Mutant Mice
To characterize Plac1 gene expression and its function,
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vector designed by IKMC (Supplemental Fig. S1A; Supple-
mental Data are available online at www.biolreprod.org).
The ORF region was replaced with a lacZ reporter transgene
to visualize Plac1 gene expression and disrupt Plac1 gene
function simultaneously. We confirmed the homologous
recombination in ES cells and germ line transmission by
PCR analysis (Supplemental Fig. S1B). Whereas LacZ
expression in the Xp–X blastocyst was observed, Plac1
expression in the Xp–X blastocyst was lower than in the
control XX blastocyst (Supplemental Fig. S1C). When we
stained the placenta with X-gal at E11.5, LacZ-positive cells
appeared only in the placenta carrying the maternally
transmitted mutant allele. Positive cells were mainly
distributed in the junctional zone, and some were in the
labyrinth zone (Supplemental Fig. S1D). At E14.5, LacZ-
positive signals were strongly detected in the encroached
junctional zone (Supplemental Fig. S1E). The expression of
Plac1 from the maternally inherited allele during placenta-
tion was consistent with previous reports [7].
Plac1 Deficiency and Preimplantation Development
To determine whether paternally expressed Plac1 plays an
important role during preimplantation development, we
collected and genotyped blastocysts from WT XX females
mated with Plac1 mutant X–Y males, and Plac1 mutant X–X
females mated with WT XY males. In either combination, the
expected number of blastocysts carrying Plac1 mutant allele
FIG. 1. The developmental viability of Plac1 mutant embryos. A) RT-PCR analysis of Plac1 using preimplantation and postimplantation embryos. Plac1
mRNA was dominantly detected in female blastocyst (E3.5). After implantation, Plac1 expression was observed in both sexes (E6.5 and E7.5). B) The
expression level of Plac1 was compared between female and male embryos (E3.5 and E7.5) by quantitative RT-PCR to compare. The Plac1 mRNA level in
female blastocysts was approximately seven times greater than in male blastocysts (E3.5; *P , 0.05). Comparable expression levels of Plac1 mRNA were
found in E7.5 female and male embryos. n.s., no significant difference. C) The proportion of mutant embryos at blastocyst stage. The blastocysts were
genotyped and sexed by PCR. The mutant embryos were obtained at the expected Mendelian ratio. D) Fecundity of Plac1 mutant mice. Plac1 mutant
females (X–X or X–X–) were mated with XY or X–Y males, and newborn pups were genotyped by PCR (a vs. b, c, d P , 0.05).














/biolreprod/article/94/1/6, 1-9/2434346 by O
saka U
niversity user on 03 February 2021
was obtained (Fig. 1C). There were no morphological or
developmental abnormalities observed in the mutant blasto-
cysts (data not shown). These results indicate that the Plac1
gene is not required for preimplantation embryonic develop-
ment.
Plac1 Deficiency and Postimplantation Development
To evaluate the effect of Plac1 deficiency in postimplanta-
tion development, Plac1 mutant female mice were mated with
mutant male mice as shown in Figure 1D. Whereas the
intercrossing with Plac1 XX female and X–Y male mice
showed normal litter size (number of pups: Xp–X, 5.5 6 1.7;
XY, 3.8 6 1.3; litter size, 9.3 6 1.5; n ¼ 30), Plac1 mutant
females (X–X) showed a decreased litter size, with reduced
numbers of the maternally mutated embryos (X–X 3 XY
mating: number of pups: XX, 2.4 6 1.3; XY, 2.9 6 1.4;
Xm–X, 0.9 6 1.2; Xm–Y, 0.3 6 0.6; litter size, 6.5 6 2.4;
n¼ 20; X–X 3 X–Y mating: number of pups: XY, 2.6 6 1.4;
Xp–X, 2.6 6 1.7; Xm–Y, 0.6 6 1.0; Xm–Xp–, 0.6 6 0.7; litter
size, 6.4 6 2.3; n¼ 37; Fig. 1D). We analyzed the proportion
of embryos produced by the cross between X–X females and
XY males in midgestational stages (E11.5;E14.5; n ¼ 15)
through late-gestational stages (E15.5;E17.5; n ¼ 6). Al-
though the number of WT embryos was comparable (midg-
estation, 3.9 6 1.0; late gestation, 3.7 6 2.3; P¼ 0.7813), Xm–
mutant embryos tended to decrease during late-gestational
stages (midgestation: Xm– mutant, 4.7 6 1.8; late-gestation:
Xm–mutant, 3.0 6 1.3; P¼ 0.0494). These results reconfirmed
that maternally expressed PLAC1 protein plays an important
role in postimplantation embryonic development [7]. Notably,
the intercrossing with Plac1 X–X– and X–Y mice gave 3.7
times more maternally mutated pups (number of pups: Xm–Y,
1.1 6 0.7; Xm–Xp–, 3.3 6 1.5; litter size, 4.4 6 1.9; n ¼ 18)
than heterozygous intercrosses (maternally mutated pups, 1.2
6 0.96 in X–X 3 XY and 1.2 6 0.86 in X–X 3 X–Y mating;
Fig. 1D).
Placental Hyperplasia and Intrauterine Growth Restriction
in Plac1 Mutant Mice
To understand when the defects appear during gestation, we
weighed fetuses and placentas obtained from the intercrossing
of Plac1 X–X female with XY male mice at the indicated
embryonic days (Supplemental Fig. S2, A and B). Placentas
carrying the Xm– mutation showed weights comparable with
those of WT placentas (WT, 70 6 23 mg; n ¼ 14; Xm–,
83 6 37 mg; n ¼ 12) at E12.5, then significantly increased
their weight during midgestation (E14.5: WT, 104 6 18 mg; n
¼ 16; Xm–, 190 6 33 mg; n ¼ 20; E16.5: WT, 86 6 21 mg;
n ¼ 16; Xm–, 203 6 55 mg; n¼ 12; Supplemental Fig. S2A).
Whereas Xm– mutated fetal weight was comparable with that of
the WT fetus during E12.5 through E14.5, Xm– mutated fetal
weight was lower than that of the WT fetus at E16.5 (E12.5:
WT, 83 6 12 mg; n ¼ 14; Xm–, 70 6 23 mg; n ¼ 12; E14.5:
WT, 267 6 42 mg; n¼ 16; Xm–, 246 6 38 mg; n¼ 20; E16.5:
WT, 770 6 52 mg; n ¼ 16; Xm–, 670 6 119 mg; n ¼ 12;
Supplemental Fig. S2B).
Histological Analysis of Plac1 Mutant Placentas
We then performed the histological analysis of Plac1
mutant placentas by PAS staining, which detects polysaccha-
rides, such as glycogen and mucosubstances, such as
glycoproteins, glycolipids, and mucins. Whereas no apparent
abnormality was found in maternally Plac1 mutated (Xm–)
placentas at E12.5 (Supplemental Fig. S2C), mutant placentas
showed overgrowth with an expanded junctional zone that
encroached into the labyrinth zone at E13.5 (Fig. 2A). No overt
developmental abnormalities were found in paternally Plac1
mutated (Xp–) placentas (Fig. 2A). Whereas the areas of the
decidua and labyrinth zone showed no difference among WT,
Xp–, and Xm– placentas, the area of the junctional zone
significantly increased in the Xm– placenta (Fig. 2B). When we
stained placentas with anti-Ki67 (cell proliferation marker)
antibody, more signals were observed in the junctional zone of
the Xm– placenta (Supplemental Fig. S3). It is noteworthy that
morphological abnormalities appeared in the Xm– mutant
placental labyrinth zone by laminin immunostaining (Fig.
2C). Although the fetal blood vessel formation of Xm– mutant
placenta was observed, adjacent maternal blood sinuses were
dilated (Fig. 2, C and D).
Transgenic Complementation of Plac1 Deficiency Using
Lentiviral Vectors
To confirm that PLAC1 deficiency is the principal cause of
the phenotype, we restored Plac1 expression by using lentiviral
(LV) vector-mediated, placenta-specific gene expression sys-
tem [15]. Blastocysts collected from Plac1 X–X females mated
with WT male mice were transduced with the LV vectors
expressing PLAC1 (LV-Plac1) and transplanted into pseudo-
pregnant mice (Fig. 3A). Placenta-specific genomic integration
of the LV-Plac1 was confirmed by PCR (Fig. 3B). When we
compared the amount of Plac1 mRNA by quantitative RT-
PCR, LV-Plac1-transduced Xm– mutant placentas showed
about five times more Plac1 mRNA than LV-EGFP-trans-
duced WT placenta (Supplemental Fig. S4). When we
transduced the maternally Plac1-mutated blastocysts (Xm–X
and Xm–Y) with LV-Plac1, the proportion was improved
compared with that of the control LV-EGFP (Xm– mutant pups
ratio was 40.4% with LV-Plac1 compared with 22.9% with
control LV-EGFP; Fig. 3C). The fetal body weight of LV-
Plac1-transduced mutant placentas was also improved (LV-
EGFP-treated Xm– mutant: 649 6 128 mg; n¼ 19; LV-Plac1-
treated Xm– mutant: 740 6 88 mg; n ¼ 21; Fig. 3D, right).
Unexpectedly, LV-Plac1-transduced mutant placentas re-
mained hyperplastic (LV-EGFP-treated Xm– mutant:
202 6 55 mg; n ¼ 12; LV-Plac1-treated Xm– mutant:
276 6 74 mg; n ¼ 15; Fig. 3D, left). Histological analysis
revealed that dilation of maternal blood sinuses in the labyrinth
zone was improved, although the hyperplastic junctional zone
remained (Fig. 3, E and F).
LV-Plac1 Transduction in WT Placentas
Whereas Plac1 deficiency caused placental hyperplasia,
overexpression of Plac1 was also reported in hyperplastic
placentas from the NT-cloned mouse [8]. Therefore, we
transduced LV-Plac1 in WT placentas to examine its
function. There was no difference in fetal development ability
when we observed at E16.5 (live fetuses:transplanted
blastocysts were 15:40 [37%] and 14:40 [35%] with LV-
EGFP and LV-Plac1, respectively). Placental weight signif-
icantly increased in the LV-Plac1 treated group (LV-EGFP-
treated WT placenta: 85.6 6 21 mg; n¼ 16; LV-Plac1-treated
WT placenta: 129 6 27.5 mg; n¼ 24; Fig. 4A). Although the
fetal weight of the LV-Plac1-treated group tended to be
smaller than that of the LV-EGFP-treated controls (LV-
EGFP-treated WT fetus: 770 6 51.9 mg; n ¼ 16; LV-Plac1-
treated WT fetus: 732 6 65 mg; n ¼ 24; Fig. 4B), it was not
significant (P¼ 0.055). Histological analysis revealed that the















/biolreprod/article/94/1/6, 1-9/2434346 by O
saka U
niversity user on 03 February 2021
FIG. 2. Histological analysis of hyperplastic placenta in Plac1 Xm– mice. A) PAS staining of placenta. At E13.5, Plac1 Xm– placenta showed hyperplasia,
expanded the junctional zone, and showed morphological abnormalities in the labyrinth zone. Plac1 Xp– placenta was normally formed. The
enlargements of the leftmost images are shown in the middle images, and the enlargements of the middle images are shown in the rightmost images. Bars
¼ 1 mm (left), 200 lm (center), and 50 lm (right). B) Morphometric analysis of placenta. The area of the junctional zone significantly increased in Xm–
mutant placenta at E13.5 (n¼ 3 per group; *P , 0.05, **P , 0.01, ***P , 0.001; n.s., no significant difference). C) Laminin immunohistochemistry of
placenta (DAB staining). Whereas fetal capillaries in the labyrinth zone were observed, neighboring maternal blood sinuses were dilated in Plac1 Xm–
placenta. Right images are magnified images of the boxes indicated in the left figures. Bars¼ 1 mm (left) and 50 lm (right). D) Width of maternal blood
sinus in the labyrinth zone at E13.5 (n ¼ 180 from 3 placenta per group; ***P , 0.001).
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FIG. 3. Transgenic complementation of Plac1 mutant mice by lentiviral vector-mediated, placenta-specific Plac1 gene transduction. A) Scheme for LV
vector-mediated transgenic complementation. Plac1 Xm–X and Xm–Y blastocysts were collected from Plac1 X–X mothers. Zona pellucida-free blastocysts
were transduced with a lentiviral vector expressing Plac1 (LV-Plac1) and were transplanted into pseudopregnant females. Primers A (5 0-
GCAACGTGCTGGTTGTTGTGCTGTCTCATC-30) and B (50-TTACATGCTCTTTTGATTGTAGACATAAGGTGG-30) were used to detect LV-Plac1 transgene.
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primers indicated in A. p.c.¼ pLV-Plac1 plasmid. C) The proportion of Plac1 mutant pups after LV-Plac1 transduction. The pups developed from the LV-
Plac1-transduced blastocysts were genotyped by PCR at birth. D) The placental and fetal body weights of Plac1 Xm– mutant mice at E16.5. The fetuses
developed from LV-Plac1-transduced mutant blastocysts were larger than those of the LV-EGFP control. The LV-Plac1-transduced mutant placenta
remained hyperplastic (*P , 0.05, **P , 0.01). We present the placental weight and fetal body weight of WT controls in Figure 4, A and B (LV-EGFP-
treated WT placenta, 85.6 6 21 mg; n ¼ 16; LV-EGFP-treated WT fetus, 770 6 51.9 mg; n ¼ 16). E) PAS staining and laminin immunostaining (DAB
staining) of LV-transduced placenta at E16.5. Hyperplastic junctional zone that encroached into the labyrinth zone was observed. The laminin
immunostaining shows that fetal capillaries and maternal blood sinus were formed normally in LV-Plac1 complemented placenta. Bars¼ 1 mm, 200 lm,
50 lm, and 50 lm, respectively from the left. F) Width of maternal blood sinus in the labyrinth zone of E16.5 LV-treated Plac1 Xm– mutant placenta (n¼
180 from 3 placenta per group; ***P , 0.001). Dilation of maternal blood sinuses was restored in LV-Plac1-transduced Xm– mutant placenta.
FIG. 4. LV-Plac1 transduction of WT placenta resulted in hyperplasia. A) The placental weight of LV-Plac1-transduced WT embryos at E16.5. LV-Plac1-
treated placentas were larger than those in the LV-EGFP-treated group (***P , 0.001). B) The fetal weight of LV-Plac1-transduced WT embryos at E16.5.
There was no significant difference between the two groups. C) Histological analysis by PAS staining and laminin immunostaining of LV-Plac1-transduced
WT placentas at E16.5. There was no apparent abnormality in the junctional and labyrinth zones. Bars¼ 1 mm, 200 lm, 50 lm, and 50 lm, respectively
from the left. D) Morphometric analysis of placenta. The area of junctional and labyrinth zones significantly increased in LV-Plac1-transduced WT
placentas at E16.5 (n¼ 3 per group; *P , 0.05). n.s., no significant difference.
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of maternal blood sinus that was observed in Plac1 KO
placenta (Fig. 4C). In addition, the areas of the junctional and
labyrinth zones significantly increased in LV-Plac1-trans-
duced placentas (Fig. 4D).
DISCUSSION
Plac1 is an X-chromosome-linked and reported to be
maternally expressed gene that plays important roles in both
placental and embryonic development [7]. In the present study,
by separating male and female blastocysts using an Xegfp
transgenic strain, we demonstrated that Plac1 gene is paternally
expressed before implantation and then switched to be
maternally expressed after implantation. Recently, transient
imprinting and aberrant allele switching have been implicated
in developmental and disease-related phenotypes [16, 17]. For
example, during mammalian development, many loci maintain
parent-of-origin DNA methylation only briefly after fertiliza-
tion [16]. Antisense noncoding RNA has also been implicated
in the imprint switch mechanism in breast cancers [17].
Because Gm35988 is listed as intragenic lincRNA from the
Plac1 locus, it may play a role in both preimplantation and
postimplantation gene expression. Although Plac1 is not
essential for preimplantation development, further studies
might elucidate the transition mechanism of gene expression
and its physiological functions.
After implantation, Plac1 is maternally expressed, and its
disruption causes impaired placentation and subsequent fatal
problems in embryos [7]. In the present study, we also
confirmed that maternal Plac1 deficiency causes fatality during
pregnancy. Unexpectedly, more than twice as many maternally
mutated pups were obtained from the intercrossing with Plac1
X–X– and X–Y mice compared with those obtained from
heterozygous intercrosses (Fig. 1D). Because all of the
offspring from the X–X– 3 X–Y cross became Plac1 null
mice, the possibility of Plac1 reactivation can be ruled out. In
general, litter size and fetal body size are usually inversely
correlated. Because the litter size from the X–X– and the X–Y
cross was reduced, we assumed that the embryos received more
nutrients from the mother. In other words, placental functions
are more critical for fetal development in competitive
circumstances.
Notably, there are some similarities and differences among
WT placenta, Plac1 mutant placenta, LV-Plac1 complemented
mutant placenta, and LV-Plac1 transduced WT placenta (Fig.
5). From the histological analysis, we observed defects in
Plac1 mutant placenta: the encroaching junctional zone, and
the morphological impairment of maternal blood sinuses in the
labyrinth zone. Lentiviral vector-mediated, placenta-specific
Plac1 expression restored the morphology of labyrinth zone
but not the placental hyperplasia with the encroaching
junctional zone. With the recent report that Plac1 is also
expressed in the fetus proper [18], the contribution of fetal
Plac1 expression should be taken into account for placental
size regulation and compartmentation of placental layers. This
is also supported by work in which WT tetraploid comple-
mentation could not restore the placental phenotypes of NT-
cloned mice [19].
Although the Plac1 gene is upregulated in NT-cloned
placentas, Plac1-deficient placentas showed phenotypes sim-
ilar to NT-cloned placentas. We transduced LV-Plac1 in
placentas specifically in WT embryos. Unexpectedly, these
placentas showed hyperplasia with normal junctional and
labyrinth zone formation. The expression level of the Plac1
transgene is approximately five times greater than that of the
endogenous gene, implicating that Plac1 overexpression
caused the placental hyperplasia. Because LV-Plac1-treated
KO and WT placentas showed comparable amounts of Plac1
mRNA in the placenta (five times more than endogenous
level), the histological difference observed in these placentas
may be attributed to the difference in fetal Plac1 expression.
With the fact that NT-cloned placental defects were normalized
with WT fetus [19], our results reinforce the importance of fetal
Plac1 expression for normal placentation.
In summary, we used gene knockout mice and a lentiviral
vector-mediated, placenta-specific gene expression system to
elucidate the Plac1 function in vivo. Our findings demonstrate
the importance of the fine tuning of Plac1 expression for
proper formation of the junctional and labyrinth zones. These
findings augment our limited knowledge of how Plac1 gene
expression is developmentally regulated and how it influences
placental formation and functions. In addition, our results
further support prior work showing the critical importance of
the fetoplacental proportion in determining total intrauterine
growth.
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